BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 25847264)

  • 1. Noninvasive measurement of aristolochic acid-DNA adducts in urine samples from aristolochic acid-treated rats by liquid chromatography coupled tandem mass spectrometry: evidence for DNA repair by nucleotide-excision repair mechanisms.
    Leung EM; Chan W
    Mutat Res; 2014; 766-767():1-6. PubMed ID: 25847264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry.
    Guo L; Wu H; Yue H; Lin S; Lai Y; Cai Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(2):153-8. PubMed ID: 21177145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of aristolochic acid-RNA adducts in the urine of aristolochic acid-treated rats by liquid chromatography-tandem mass spectrometry.
    Leung EM; Chan W
    Chem Res Toxicol; 2015 Apr; 28(4):567-9. PubMed ID: 25715065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of urinary aristolactams by on-line solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry.
    Chiang SY; Shih WC; Liao HT; Shu PC; Wey MT; Huang HF; Wu KY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2494-500. PubMed ID: 21802379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry.
    Chan W; Yue H; Poon WT; Chan YW; Schmitz OJ; Kwong DW; Wong RN; Cai Z
    Mutat Res; 2008 Nov; 646(1-2):17-24. PubMed ID: 18812181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous toxicokinetic studies of aristolochic acid I and II and aristolactam I and II using a newly-developed microdialysis liquid chromatography-tandem mass spectrometry.
    Chiang SY; Wey MT; Luo YS; Shih WC; Chimeddulam D; Hsu PC; Huang HF; Tsai TH; Wu KY
    Food Chem Toxicol; 2023 Jul; 177():113856. PubMed ID: 37257633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
    Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
    Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry.
    Goodenough AK; Schut HA; Turesky RJ
    Chem Res Toxicol; 2007 Feb; 20(2):263-76. PubMed ID: 17305409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of DNA and RNA Adduct Formation: Significantly Higher Levels of RNA than DNA Modifications in the Internal Organs of Aristolochic Acid-Dosed Rats.
    Leung EM; Chan W
    Chem Res Toxicol; 2015 Feb; 28(2):248-55. PubMed ID: 25555167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of Protein Adducts of Aristolochic Acid I by Liquid Chromatography-Tandem Mass Spectrometry: A Novel Method for Biomonitoring Aristolochic Acid Exposure.
    Chan CK; Chan KJ; Liu N; Chan W
    Chem Res Toxicol; 2021 Jan; 34(1):144-153. PubMed ID: 33410325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.
    Yun BH; Rosenquist TA; Sidorenko V; Iden CR; Chen CH; Pu YS; Bonala R; Johnson F; Dickman KG; Grollman AP; Turesky RJ
    Chem Res Toxicol; 2012 May; 25(5):1119-31. PubMed ID: 22515372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the metabolism and reductive activation of carcinogenic aristolochic acids in rats.
    Chan W; Luo HB; Zheng Y; Cheng YK; Cai Z
    Drug Metab Dispos; 2007 Jun; 35(6):866-74. PubMed ID: 17344338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids.
    Chan W; Zheng Y; Cai Z
    J Am Soc Mass Spectrom; 2007 Apr; 18(4):642-50. PubMed ID: 17208007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
    Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis and mass spectrometric analysis of aristolochic acid-deoxyguanosine adducts].
    Ji WX; Liu MX; Yang CD; Chen YP
    Yao Xue Xue Bao; 2008 Mar; 43(3):295-8. PubMed ID: 18630267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of DNA Adducts in Target and Nontarget Organs of Aristolochic Acid I-Exposed Rats: Correlating DNA Adduct Levels with Organotropic Activities.
    Liu Y; Chan CK; Jin L; Wong SK; Chan W
    Chem Res Toxicol; 2019 Mar; 32(3):397-399. PubMed ID: 30604963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantitation of dG-AAI and dA-AAI adducts by 32P-postlabeling methods in urothelium and exfoliated cells in urine of rats treated with aristolochic acid I.
    Fernando RC; Schmeiser HH; Nicklas W; Wiessler M
    Carcinogenesis; 1992 Oct; 13(10):1835-9. PubMed ID: 1423842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling/polyacrylamide gel electrophoresis analysis.
    Dong H; Suzuki N; Torres MC; Bonala RR; Johnson F; Grollman AP; Shibutani S
    Drug Metab Dispos; 2006 Jul; 34(7):1122-7. PubMed ID: 16611860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.